Omniscan intelligence · 1 January 2026–31 July 2026

UK pharma media reputation tracker

Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 4,868 UK earned-media mentions, Jan–Jul 2026.

Reporting period
1 January 2026–31 July 2026
Articles analysed
6,021
Earned-media mentions
4,868
Organisations compared
10

Organisations in the benchmark

  • GSK
  • AstraZeneca
  • Pfizer
  • Eli Lilly
  • Novartis
  • MSD
  • Roche
  • Sanofi
  • Novo Nordisk
  • Moderna

What the benchmark compares

Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.

Eli Lilly led average share of voice at 21.3%.